Pestivirus mutant for use in a vaccine

Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Virus or component thereof

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

Reexamination Certificate

active

08071108

ABSTRACT:
The present invention comprises new pestivirus mutants, characterized in that the mutants are based on a cp strain of the virus wherein part of the gene sequence encoding the Npro region is deleted, except that the deleted part does not encompass the coding sequence for the N-terminal twelve amino acids of the Npro protein. Preferably the pestivirus is the Bovine Viral Diarrhea Virus (BVDV). It was found that a mutant according to the invention is a safe and efficient vaccine candidate.

REFERENCES:
patent: 7572455 (2009-08-01), Meyers et al.
patent: 1 013 757 (2000-06-01), None
patent: 1 161 537 (2006-10-01), None
patent: WO 2005/111201 (2005-11-01), None
Gil et al, Journal of Virology, Jan. 2006, vol. 80, No. 2, pp. 900-911.
Kupefermann et al, Journal of Virology, 1996, vol. 70, No. 11, pp. 8175-8181.
Zemke et al, Veterinary Microbiology, 2010, vol. 142, pp. 69-80.
Mischkale et al, Veterinary Microbiology, 2010, vol. 142, pp. 3-12.
Behrens, et al., “Characterization of an Autonomous Subgenomic Pestivirus RNA Replicon”, Journal of Virology, vol. 72, No. 3, pp. 2364-2372 (Mar. 1998).
Fletcher, et al., “The influence of viral coding sequences on pestivirus IRES activity reveals further parallels with translation initiation in prokaryotes”, RNA, vol. 8, No. 12, pp. 1558-1571 (Dec. 2002).
Kupfermann, et al., “Bovine Viral Diarrhea: Characterization of a Cytopathogenic Defective Interfering Particle with Two Internal Deletions”, Journal of Virology, vol. 70, No. 11, pp. 8175-8181 (1996).
Lai, et al., “Generation and Characterization of a Hepatitis C Virus NS3 Protease-Dependent Bovine Viral Diarrhea Virus”, Journal of Virology, vol. 74, No. 14, pp. 6339-6347 (Jul. 2000).
Mayer, et al., “Attenuation of classical swine fever virus by deletion of the viral Nprogene”, Vaccine, vol. 22, No. 3-4, pp. 317-328 (Jan. 2004).
Moser, et al., “Cytopathogenic and Noncytopathogenic RNA Replicons of Classical Swine Fever Virus”, Journal of Virology, Vo. 73, No. 9, pp. 7787-7794 (Sep. 1999).
Myers, et al., “Efficient Translation Initiation Is Required for Replication of Bovine Viral Diarrhea Virus Subgenomic Replicons”, Journal of Virology, vol. 75, No. 9, pp. 4226-4238 (May 2001).
Tautz, et al., “Establishment and Characterizatin of Cytopathogenic and Noncytopathogenic Pestivirus Replicons”, Journal of Virology, vol. 73, No. 11, pp. 9422-9432 (Nov. 1999).
Tratschin, et al., “Classical Swine Fever Virus Leader Proteinase NproIs Not Required for viral Replication in Cell Culture”, Journal of Virology, vol. 72, No. 9, pp. 7681-7684 (Sep. 1998).
PCT International Search Report dated Dec. 4, 2007 for corresponding PCT Application No. PCT/EP2007/059923.
Hoffman, B. et al., “A Universal Heterologous Internal Control System for Duplex Real-Time RT-PCR Assays Used in a Detection System for Pestiviruses” (Abstract), Journal of Virological Methods, 136(1-2):200-209, (Sep. 2006).
Maurer, Roland et al., “Oronasal Vaccination with Classical Swine Fever Virus (CSFV) Replicon Particles with Either Partial or Complete Deletion of the E2 Gene Induces Partial Protection Against Lethal Challenge with Highly Virulent CSFV”, Vaccine, 23:3318-3328, (2005).
Meyers, Gregor et al., “Recovery of Cytopathogenic and Noncytopathogenic Bovine Viral Diarrhea Viruses from cDNA Constructs”, Journal of Virology, 70(12):8606-8613 (Dec. 1996).
Wolfmeyer, A. et al., “Genomic (5'UTR) and Serological Differences Among German BVDV Field Isolates”, Archives of Virology, 142:2049-2057, (1997).

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Pestivirus mutant for use in a vaccine does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Pestivirus mutant for use in a vaccine, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pestivirus mutant for use in a vaccine will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-4311632

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.